Brandon Michael Kitay MD PhD
Neuropsychiatry, Integrative Psychiatry
Assistant Professor Dept. Psychiatry and Behavioral Sciences Adult Psychiatry and Neuromodulation Divisions Emory University School of Medicine Director, Behavioral Health Integration Emory Healthcare
Join to View Full Profile
12 Executive Park Dr NEAtlanta, GA 30329
Dr. Kitay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Psychiatry, 2014 - 2018
University of Miami Leonard M. Miller School of MedicineClass of 2014
Certifications & Licensure
GA State Medical License 2020 - 2025
CT State Medical License 2016 - 2020
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide Start of enrollment: 2014 May 23
- A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression Start of enrollment: 2016 Jun 09
- ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) Start of enrollment: 2017 Apr 07
- Join now to see all
Publications & Presentations
PubMed
- A Retrospective Analysis of the Impact of Electroconvulsive Therapy on Anxiety Symptoms in Patients With Treatment-Resistant Depression.Julia Laszcz, Chenyang Wang, Patricio Riva-Posse, Jonathan Kim, Valeriya Tsygankova
The Journal of ECT. 2025-01-24 - 3 citationsCognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study pro...Brandon M Kitay, Eva Murphy, Matthew Macaluso, Philip R Corlett, Rachel Hershenberg
Psychiatry Research. 2023-12-01 - Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?John C Fortney, Anna D Ratzliff, Brittany E Blanchard, Morgan Johnson, Lori Ferro
Annals of Internal Medicine. 2023-10-01
Press Mentions
Can One of the Best Treatments for Depression Move Past Its Old Reputation?December 12th, 2024- Emory Healthcare, Goizueta Institute Partner with NeuroFlow to Scale Integrated Behavioral Health ProgramMay 11th, 2023
- Emory Healthcare Adds Digital Health Tools to New Behavioral Health ProgramMay 11th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
